← Eichor
Study identifier: NCT05765110 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease

Condition: Parkinson Disease  ·  Sponsor: Insel Gruppe AG, University Hospital Bern

PhaseNA
Planned participants80
Who can joinAll sexes, 30 Years to 75 Years
Healthy volunteersYes

About this study

With this study, the investigators want to investigate whether computerized speech analysis can be used to reliably and objectively detect motor, emotional, and cognitive fluctuations in Parkinson's disease patients.

This description comes directly from the study's public registry record.

Talk to the study team

Paul Krack, Prof.  ·  31 66 4 03 71  ·  paul.krack@insel.ch

Mario Sousa, MD  ·  31 664 23 49  ·  mario.sousa@insel.ch

Always discuss trial participation with your own doctor first.

Locations (2)

Czech Technical University PraguePrague, CzechiaActive Not Recruiting
University Hospital Inselspital, BerneBern, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05765110